Colgate-Palmolive (NYSE:CL) Price Target Cut to $102.00 by Analysts at JPMorgan Chase & Co.

Colgate-Palmolive (NYSE:CL) had its target price dropped by equities researchers at JPMorgan Chase & Co. from $104.00 to $102.00 in a research note issued on Monday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 5.72% from the stock’s previous close.

A number of other analysts also recently weighed in on CL. Bank of America increased their target price on shares of Colgate-Palmolive from $100.00 to $105.00 and gave the company a “buy” rating in a research report on Monday. Jefferies Financial Group restated a “hold” rating and set a $89.00 target price (up from $88.00) on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Sanford C. Bernstein reiterated a “market perform” rating on shares of Colgate-Palmolive in a research note on Thursday, August 13th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $101.00 target price (up from $99.00) on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Finally, UBS Group reiterated a “buy” rating and issued a $112.00 price target on shares of Colgate-Palmolive in a report on Monday. Thirteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $99.39.

Colgate-Palmolive Price Performance

Shares of CL traded up $1.19 during trading hours on Monday, reaching $96.48. The stock had a trading volume of 590,249 shares, compared to its average volume of 5,621,402. The company has a debt-to-equity ratio of 13.82, a quick ratio of 0.30 and a current ratio of 0.46. Colgate-Palmolive has a 12 month low of $74.54 and a 12 month high of $99.33. The stock has a market capitalization of $76.91 billion, a PE ratio of 37.81, a PEG ratio of 4.59 and a beta of 0.31. The company’s 50-day moving average is $89.54 and its two-hundred day moving average is $89.65.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, October 30th. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.04. Colgate-Palmolive had a return on equity of 607.88% and a net margin of 9.65%. The company had revenue of $5.37 billion for the quarter, compared to analysts’ expectations of $5.34 billion. During the same period in the previous year, the business posted $0.91 earnings per share. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. Research analysts expect that Colgate-Palmolive will post 3.89 EPS for the current year.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 161,021 shares of the stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the sale, the chief executive officer owned 362,231 shares in the company, valued at $33,296,273.52. This represents a 30.77% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director John T. Cahill sold 4,170 shares of the firm’s stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $93.37, for a total value of $389,352.90. Following the completion of the transaction, the director directly owned 28,373 shares of the company’s stock, valued at $2,649,187.01. The trade was a 12.81% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 175,191 shares of company stock worth $16,110,903. 0.43% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Colgate-Palmolive

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Chicago Partners Investment Group LLC lifted its stake in Colgate-Palmolive by 26.3% in the 3rd quarter. Chicago Partners Investment Group LLC now owns 28,514 shares of the company’s stock worth $2,681,000 after purchasing an additional 5,940 shares in the last quarter. Compass Financial Management LLC increased its holdings in shares of Colgate-Palmolive by 93.1% in the third quarter. Compass Financial Management LLC now owns 1,757 shares of the company’s stock worth $150,000 after purchasing an additional 847 shares during the period. Rakuten Investment Management Inc. boosted its stake in Colgate-Palmolive by 9.3% during the third quarter. Rakuten Investment Management Inc. now owns 140,679 shares of the company’s stock valued at $12,163,000 after buying an additional 11,986 shares during the period. AIA Group Ltd boosted its stake in Colgate-Palmolive by 140.5% during the third quarter. AIA Group Ltd now owns 47,369 shares of the company’s stock valued at $4,042,000 after buying an additional 27,670 shares during the period. Finally, Provenance Wealth Advisors LLC purchased a new position in Colgate-Palmolive during the third quarter worth about $526,000. 80.41% of the stock is currently owned by institutional investors.

Trending Headlines about Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Colgate-Palmolive exceeded third-quarter expectations, reporting adjusted EPS of $0.97 versus the $0.93 consensus and revenue of $5.37 billion, up 4.6% year over year. Management also raised its margin and EPS outlook while narrowing its 2026 sales-growth range. Colgate-Palmolive sales rise 4.6% and it lifts margin and EPS outlook
• Positive Sentiment: Royal Bank of Canada raised its price target from $104 to $105 and maintained an “outperform” rating, implying roughly 8.9% potential upside from the referenced share price. Royal Bank of Canada recommendations
• Positive Sentiment: Analysts broadly lifted their forecasts after the earnings beat and higher EPS guidance, reinforcing the view that pricing, productivity initiatives and resilient household-products demand are supporting results. Colgate-Palmolive analysts boost forecasts after upbeat Q3 earnings
• Positive Sentiment: Through the third quarter, free cash flow increased 7% and the company returned $2.2 billion to shareholders year to date, supporting the investment case for cash generation and capital returns. Colgate-Palmolive key takeaways for long-term investors

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.